The University of Southampton
University of Southampton Institutional Repository

Improving patient access to novel medical technologies in Europe

Improving patient access to novel medical technologies in Europe
Improving patient access to novel medical technologies in Europe
The European Society of Cardiology (ESC) organized a one-day workshop with clinicians, health economic experts, and health technology appraisal experts to discuss the equity of patient access to novel medical technologies in Europe. Two index technologies were considered: implantable cardioverter defibrillators (ICDs) and drug-eluting stents (DES). The use of ICDs range from 35 implants/million population in Portugal to 166 implants/million population in Germany, whereas for implants of DES (as percentage of total stents) it is lowest in Germany at 14% and high in Portugal at 65%. These differences can in part be explained by a lack of structured implementation of guidelines, the direct cost in relation to the overall healthcare budget, and to differences in procedures and models applied by Health Technology Assessment (HTA) agencies in Europe. The workshop participants concluded that physicians need to be involved in a more structured way in HTA and need to become better acquainted with its methods and terminology. Clinical guidelines should be systematically translated, explained, disseminated, updated, and adopted by cardiologists in Europe. Clinically appropriate, consistent and transparent health economic models need to be developed and high-quality international outcome and cost data should be used. A process for funding of a technology should be developed after a positive recommendation from HTA agencies. Both the ESC and the national cardiac societies should build-up health economic expertise and engage more actively in discussions with stakeholders involved in the provision of healthcare.
health technology assessment, des, drug eluting stents, icd, iplantable cardioverter defibrillators, health economics, esc guidelines, funding
0195-668X
882-885
Kearney, Peter
155e868c-236a-4838-88de-d4da36207282
Stokoe, Graham
8a5066a6-08b8-4b04-9b78-fc67dc49ce8f
Breithardt, Günter
b733b43c-dc8b-4052-b268-2d7b4140602e
Longson, Carole
faf52ddd-4f35-4518-8441-7c56e08fbd0f
Marco, Jean
b7c7e6fa-40a5-46c9-8b1a-ccf87d928126
Morgan, John
b9446d5b-771e-4065-a84d-d05050c7bbe4
Priori, Silvia
c2b3eb47-2034-4781-92dd-5602ec270e33
Ruether, Alric
c8663e38-7f4a-4649-b862-1b1a0b0ba262
Taylor, Rod
12fb1379-fab8-4713-9c5d-2662b5b6ca14
Hertog, Michaël
9e55f833-aceb-4f99-ba7c-82af2a681105
Kearney, Peter
155e868c-236a-4838-88de-d4da36207282
Stokoe, Graham
8a5066a6-08b8-4b04-9b78-fc67dc49ce8f
Breithardt, Günter
b733b43c-dc8b-4052-b268-2d7b4140602e
Longson, Carole
faf52ddd-4f35-4518-8441-7c56e08fbd0f
Marco, Jean
b7c7e6fa-40a5-46c9-8b1a-ccf87d928126
Morgan, John
b9446d5b-771e-4065-a84d-d05050c7bbe4
Priori, Silvia
c2b3eb47-2034-4781-92dd-5602ec270e33
Ruether, Alric
c8663e38-7f4a-4649-b862-1b1a0b0ba262
Taylor, Rod
12fb1379-fab8-4713-9c5d-2662b5b6ca14
Hertog, Michaël
9e55f833-aceb-4f99-ba7c-82af2a681105

Kearney, Peter, Stokoe, Graham, Breithardt, Günter, Longson, Carole, Marco, Jean, Morgan, John, Priori, Silvia, Ruether, Alric, Taylor, Rod and Hertog, Michaël (2006) Improving patient access to novel medical technologies in Europe. European Heart Journal, 27 (7), 882-885. (doi:10.1093/eurheartj/ehi794).

Record type: Article

Abstract

The European Society of Cardiology (ESC) organized a one-day workshop with clinicians, health economic experts, and health technology appraisal experts to discuss the equity of patient access to novel medical technologies in Europe. Two index technologies were considered: implantable cardioverter defibrillators (ICDs) and drug-eluting stents (DES). The use of ICDs range from 35 implants/million population in Portugal to 166 implants/million population in Germany, whereas for implants of DES (as percentage of total stents) it is lowest in Germany at 14% and high in Portugal at 65%. These differences can in part be explained by a lack of structured implementation of guidelines, the direct cost in relation to the overall healthcare budget, and to differences in procedures and models applied by Health Technology Assessment (HTA) agencies in Europe. The workshop participants concluded that physicians need to be involved in a more structured way in HTA and need to become better acquainted with its methods and terminology. Clinical guidelines should be systematically translated, explained, disseminated, updated, and adopted by cardiologists in Europe. Clinically appropriate, consistent and transparent health economic models need to be developed and high-quality international outcome and cost data should be used. A process for funding of a technology should be developed after a positive recommendation from HTA agencies. Both the ESC and the national cardiac societies should build-up health economic expertise and engage more actively in discussions with stakeholders involved in the provision of healthcare.

This record has no associated files available for download.

More information

Published date: April 2006
Keywords: health technology assessment, des, drug eluting stents, icd, iplantable cardioverter defibrillators, health economics, esc guidelines, funding

Identifiers

Local EPrints ID: 61281
URI: http://eprints.soton.ac.uk/id/eprint/61281
ISSN: 0195-668X
PURE UUID: 2b54cf87-8f54-4e5e-9df2-8ac86b136e07

Catalogue record

Date deposited: 29 Sep 2008
Last modified: 15 Mar 2024 11:25

Export record

Altmetrics

Contributors

Author: Peter Kearney
Author: Graham Stokoe
Author: Günter Breithardt
Author: Carole Longson
Author: Jean Marco
Author: John Morgan
Author: Silvia Priori
Author: Alric Ruether
Author: Rod Taylor
Author: Michaël Hertog

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×